Journal article
ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.
Abstract
OBJECTIVE: To demonstrate the superiority of enoxaparin compared with unfractionated heparin (UFH) in preventing recurrent angina, myocardial infarction (MI) and death in patients presenting with unstable angina or non-Q wave MI.
DESIGN: A prospective, randomized, double-blind multicentre trial.
Authors
Demers C
Journal
Canadian Journal of Cardiology, Vol. 14 Suppl E, , pp. 15e–19e
Publication Date
August 1998
ISSN
0828-282X